Ağız yanması sendromu

herhangi bir patolojik değişik- liğin saptanamadığı, oral yanma veya benzer ağrılar ile karakterize bir hastalıktır. Bu durum, orta yaş ve üstü kadınlar arasında daha sık görülür. Çeşitli lokal, siste- mik ve psikolojik faktörler ağız yanması sendromunun olası nedenleri olarak kabul edilse de, ağız hastalıkları alanında hala tam olarak açıklığa kavuşturalamamış bir durumdur. Bu derlemede, ağız yanması sendromu çeşitli açılardan ele alınmış, sendromla ilgili en son bil- gilere yer verilmiş ve tedavi seçenekleri sunulmuştur

Burning mouth syndrome

Burning mouth syndrome BMS is characterized by oral burning or similar pain in the absence of detectable oral mucosa changes. This condition is more common among middle-aged and elderly women. Although various local, systemic, and psychological factors are considered to be possible causes of BMS, it is still a challenge in the field of oral medicine. The aim of this review is to discuss several aspects of BMS, update current knowledge, and provide guidelines for patient management.

___

  • Detailed descriptions of pain syndromes. In: Merskey H, Bogduk N, editors. Classification of chronic pain: descriptions of chronic pain syndromes and defini- tions of pain terms. 2nd ed. Seattle: IASP Press; 1994. p. 37-205.
  • John B, Joanna Z. Burning mouth syndrome. In: Clinical evidence. London: BMJ Publishing Group; 2000. p. 753-7.
  • van der Waal I. The burning mouth syndrome. Copenhagen: Munksgaard; 1990.
  • Hakeberg M, Hallberg LR, Berggren U. Burning mouth syndrome: experiences from the perspective of female patients. Eur J Oral Sci 2003;111:305-11.
  • Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999;28:350-4.
  • Asplund R. Nocturia and the burning mouth syn- drome (BMS) in the elderly. Arch Gerontol Geriatr 2005;41:255-60.
  • Hakeberg M, Berggren U, Hagglin C, Ahlqwist M. Reported burning mouth symptoms among middle-aged and elderly women. Eur J Oral Sci 1997; 105:539-43.
  • Palacios-Sanchez MF, Jordana-Comin X, Garcia-Sivoli CE. Burning mouth syndrome: a retrospective study of 140 cases in a sample of Catalan population. Med Oral Patol Oral Cir Bucal 2005;10:388-93.
  • Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc 1993;124:115-21.
  • Tammiala-Salonen T, Hiidenkari T, Parvinen T. Burning mouth in a Finnish adult population. Community Dent Oral Epidemiol 1993;21:67-71.
  • Basker RM, Sturdee DW, Davenport JC. Patients with burning mouths. A clinical investigation of causative factors, including the climacteric and diabetes. Br Dent J 1978;145:9-16.
  • Lamey PJ, Lewis MA. Oral medicine in practice: burn- ing mouth syndrome. Br Dent J 1989;167:197-200.
  • Soares MS, Chimenos-Kustner E, Subira-Pifarre C, Rodriguez de Rivera-Campillo ME, Lopez-Lopez J. Association of burning mouth syndrome with xeros- tomia and medicines. Med Oral Patol Oral Cir Bucal 2005;10:301-8.
  • Gall-Troselj K, Mravak-Stipetic M, Jurak I, Ragland WL, Pavelic J. Helicobacter pylori colonization of tongue mucosa - increased incidence in atrophic glossitis and burning mouth syndrome (BMS). J Oral Pathol Med 2001;30:560-3.
  • Eguia Del Valle A, Aguirre-Urizar JM, Martinez- Conde R, Echebarria-Goikouria MA, Sagasta-Pujana O. Burning mouth syndrome in the Basque Country: a preliminary study of 30 cases. Med Oral 2003;8:84-90.
  • Chen Q, Samaranayake LP. Growth of the fungal pathogen Candida in parotid saliva of patients with burning mouth syndrome. Microbios 2000;102:45-52.
  • Vitkov L, Weitgasser R, Hannig M, Fuchs K, Krautgartner WD. Candida-induced stomatopyrosis and its relation to diabetes mellitus. J Oral Pathol Med 2003;32:46-50.
  • Gorsky M, Silverman S Jr, Chinn H. Burning mouth syndrome: a review of 98 cases. J Oral Med 1987;42:7-9.
  • Lamey PJ, Lamb AB. Prospective study of aetio- logical factors in burning mouth syndrome. Br Med J 1988;296:1243-6.
  • Paterson AJ, Lamb AB, Clifford TJ, Lamey PJ. Burning mouth syndrome: the relationship between the HAD scale and parafunctional habits. J Oral Pathol Med 1995;24:289-92.
  • Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syn- drome: overview and patient management. Crit Rev Oral Biol Med 2003;14:275-91.
  • Miyamoto SA, Ziccardi VB. Burning mouth syndrome. Mt Sinai J Med 1998;65:343-7.
  • Virgili A, Corazza M, Trombelli L, Arcidiacono A. Burning mouth syndrome: the role of contact hyper- sensitivity. Acta Derm Venereol 1996;76:488-90.
  • Purello-D’Ambrosio F, Gangemi S, Minciullo P, Ricciardi L, Merendino RA. Burning mouth syn- drome due to cadmium in a denture wearer. J Investig Allergol Clin Immunol 2000;10:105-6.
  • Bergdahl BJ, Anneroth G, Anneroth I. Clinical study of patients with burning mouth. Scand J Dent Res 1994;102:299-305.
  • Pigatto PD, Guzzi G, Persichini P, Barbadillo S. Recovery from mercury-induced burning mouth syndrome due to mercury allergy. Dermatitis 2004; 15:75-7.
  • Main DM, Basker RM. Patients complaining of a burn- ing mouth. Further experience in clinical assessment and management. Br Dent J 1983;154:206-11.
  • Ali A, Bates JF, Reynolds AJ, Walker DM. The burning mouth sensation related to the wearing of acrylic den- tures: an investigation. Br Dent J 1986;161:444-7.
  • Lauria G, Majorana A, Borgna M, Lombardi R, Penza P, Padovani A, et al. Trigeminal small-fiber sensory neu- ropathy causes burning mouth syndrome. Pain 2005; 115:332-7.
  • Granot M, Nagler RM. Association between regional idiopathic neuropathy and salivary involvement as the possible mechanism for oral sensory complaints. J Pain 2005;6:581-7.
  • Hershkovich O, Nagler RM. Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gusta- tory disturbances. Arch Oral Biol 2004;49:515-22.
  • Nagler RM, Hershkovich O. Sialochemical and gusta- tory analysis in patients with oral sensory complaints. J Pain 2004;5:56-63.
  • Lehman CD, Bartoshuk LM, Catalanotto FC, Kveton JF, Lowlicht RA. Effect of anesthesia of the chorda tympani nerve on taste perception in humans. Physiol Behav 1995;57:943-51.
  • Chimenos-Kustner E, Marques-Soares MS. Burning mouth and saliva. Med Oral 2002;7:244-53.
  • Bergdahl M. Salivary flow and oral complaints in adult dental patients. Community Dent Oral Epidemiol 2000; 28:59-66.
  • Tammiala-Salonen T, Soderling E. Protein composi- tion, adhesion, and agglutination properties of saliva in burning mouth syndrome. Scand J Dent Res 1993; 101:215-8.
  • Lamey PJ, Murray BM, Eddie SA, Freeman RE. The secretion of parotid saliva as stimulated by 10% citric acid is not related to precipitating factors in burning mouth syndrome. J Oral Pathol Med 2001;30:121-4.
  • van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardisation of ter- minology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:179-83.
  • Asplund R. Nocturia in the elderly in relation to thirst, dry mouth and dry eyes. Can J Urol 2004;11:2322-6.
  • Friedlander AH, Runyon C. Polymyalgia rheumatica and temporal arteritis. Oral Surg Oral Med Oral Pathol 1990;69:317-21.
  • Vucicevic-Boras V, Alajbeg I, Brozovic S, Mravak- Stipetic M. Burning mouth syndrome as the initial sign of multiple myeloma. Oral Oncology Extra 2004; 40:13-5.
  • Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med 1998;338:1601-7.
  • Vucicevic-Boras V, Lukinac LJ, Cekic-Arambasin A. Evaluation of tumour markers in patients with burn- ing mouth syndrome. Oral Oncol 2003;39:742-4.
  • Heir GM. Ciguatera neurotoxin poisoning mimick- ing burning mouth syndrome. Quintessence Int 2005; 36:547-50.
  • Gibson J, Lamey PJ, Lewis M, Frier B. Oral mani- festations of previously undiagnosed non-insulin dependent diabetes mellitus. J Oral Pathol Med 1990;19:284-7.
  • Carrington J, Getter L, Brown RS. Diabetic neuropa- thy masquerading as glossodynia. J Am Dent Assoc 2001;132:1549-51.
  • Tourne LP, Fricton JR. Burning mouth syndrome. Critical review and proposed clinical management. Oral Surg Oral Med Oral Pathol 1992;74:158-67.
  • Garcia-Bravatti M. Re: Burning mouth syndrome. Am J Gastroenterol 1996;91:1281-2.
  • Rhodus NL, Carlson CR, Miller CS. Burning mouth (syndrome) disorder. Quintessence Int 2003;34:587-93.
  • Shils ME, Olson JA, Shike M, Ross AC, editors. Modern nutrition in health and disease. 9th ed. Baltimore: Lippincott Williams & Wilkins; 1999.
  • Maresky LS, van der Bijl P, Gird I. Burning mouth syndrome. Evaluation of multiple variables among 85 patients. Oral Surg Oral Med Oral Pathol 1993;75: 303-7.
  • Lamey PJ, Hammond A, Allam BF, McIntosh WB. Vitamin status of patients with burning mouth syn- drome and the response to replacement therapy. Br Dent J 1986;160:81-4.
  • Hugoson A, Thorstensson B. Vitamin B status and response to replacement therapy in patients with burning mouth syndrome. Acta Odontol Scand 1991; 49:367-75.
  • Vucicevic-Boras V, Topic B, Cekic-Arambasin A, Zadro R, Stavljenic-Rukavina A. Lack of association between burning mouth syndrome and hematinic deficiencies. Eur J Med Res 2001;6:409-12.
  • Ship JA, Grushka M, Lipton JA, Mott AE, Sessle BJ, Dionne RA. Burning mouth syndrome: an update. J Am Dent Assoc 1995;126:842-53.
  • Grushka M. Clinical features of burning mouth syn- drome. Oral Surg Oral Med Oral Pathol 1987;63:30-6.
  • Santoro V, Caputo G, Peluso F. Clinical and therapeu- tic experience in twenty eight patients with burning mouth syndrome. Minerva Stomatol 2005;54:489-96.
  • Forabosco A, Criscuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S, et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol 1992; 73:570-4.
  • Tarkkila L, Linna M, Tiitinen A, Lindqvist C, Meurman JH. Oral symptoms at menopause-the role of hormone replacement therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:276-80.
  • Ship JA, Patton LL, Tylenda CA. An assessment of salivary function in healthy premenopausal and post- menopausal females. J Gerontol 1991;46:M11-5.
  • Evans RW, Drage LA. Burning mouth syndrome. Headache 2005;45:1079-81.
  • Goss AN. Sore tongue. N Z Dent J 1973;69:194-201.
  • Abdollahi M, Radfar M. A review of drug-induced oral reactions. J Contemp Dent Pract 2003;4:10-31.
  • Gavras H, Brunner HR. Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure. Hypertension 2001;37:342-5.
  • Vlasses PH, Rotmensch HH, Ferguson RK, Sheaffer SL. “Scalded mouth” caused by angiotensin-convert- ing-enzyme inhibitors. Br Med J 1982; 284:1672-3.
  • Drucker CR, Johnson TM. Captopril glossopyrosis. Arch Dermatol 1989;125:1437-8.
  • Savino LB, Haushalter NM. Lisinopril-induced “scalded mouth syndrome”. Ann Pharmacother 1992; 26:1381-2.
  • Brown RS, Krakow AM, Douglas T, Choksi SK. “Scalded mouth syndrome” caused by angiotensin converting enzyme inhibitors: two case reports. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:665-7.
  • Triantos D, Kanakis P. Stomatodynia (burning mouth) as a complication of enalapril therapy. Oral Dis 2004; 10:244-5.
  • Castells X, Rodoreda I, Pedros C, Cereza G, Laporte JR. Drug points: Dysgeusia and burning mouth syndrome by eprosartan. BMJ 2002;325:1277.
  • Culhane NS, Hodle AD. Burning mouth syndrome after taking clonazepam. Ann Pharmacother 2001;35:874-6.
  • Levenson JL. Burning mouth syndrome as a side effect of SSRIs. J Clin Psychiatry 2003;64:336-7.
  • Glass BJ. Drug-induced xerostomia as a cause of glos- sodynia. Ear Nose Throat J 1989;68:776-81.
  • Pajukoski H, Meurman JH, Halonen P, Sulkava R. Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseas- es. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:641-9.
  • Hagelberg N, Forssell H, Rinne JO, Scheinin H, Taiminen T, Aalto S, et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 2003; 101:149-54.
  • Jaaskelainen SK, Rinne JO, Forssell H, Tenovuo O, Kaasinen V, Sonninen P, et al. Role of the dopamin- ergic system in chronic pain-a fluorodopa-PET study. Pain 2001;90:257-60.
  • Forssell H, Jaaskelainen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002;99:41-7.
  • Jaaskelainen SK, Forssell H, Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain 1997;73:455-60.
  • Evinger C, Basso MA, Manning KA, Sibony PA, Pellegrini JJ, Horn AK. A role for the basal ganglia in nicotinic modulation of the blink reflex. Exp Brain Res 1993;92:507-15.
  • Femiano F, Gombos F, Scully C. Burning mouth syn- drome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 2004;9:8-13.
  • Lamey PJ, Freeman R, Eddie SA, Pankhurst C, Rees T. Vulnerability and presenting symptoms in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:48-54.
  • Al Quran FA. Psychological profile in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:339-44.
  • Grushka M, Kawalec J, Epstein JB. Burning mouth syndrome: evolving concepts. Oral Maxillofac Surg Clin North Am 2000;12:287-95.
  • Woda A, Pionchon P. A unified concept of idiopathic orofacial pain: pathophysiologic features. J Orofac Pain 2000;14:196-212.
  • Grushka M, Sessle BJ. Burning mouth syndrome. Dent Clin North Am 1991;35:171-84.
  • Ünür M, Onur ÖD. Ağız hastalıklarının teşhis ve teda- visi. İstanbul: Quintessence Yayıncılık; 2003.
  • Lamey PJ. Burning mouth syndrome: approach to suc- cessful management. Dent Update 1998;25:298-300.
  • Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician 2002;65:615-20.
  • Woda A, Navez ML, Picard P, Gremeau C, Pichard- Leandri E. A possible therapeutic solution for stomato- dynia (burning mouth syndrome). J Orofac Pain 1998; 12:272-8.
  • Gremeau-Richard C, Woda A, Navez ML, Attal N, Bouhassira D, Gagnieu MC, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 2004;108:51-7.
  • Grushka M, Epstein J, Mott A. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:557-61.
  • Gorsky M, Silverman S Jr, Chinn H. Clinical character- istics and management outcome in the burning mouth syndrome. An open study of 130 patients. Oral Surg Oral Med Oral Pathol 1991;72:192-5.
  • Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain 1987;31:199-209.
  • McQuay HJ, Carroll D, Glynn CJ. Low dose amitrip- tyline in the treatment of chronic pain. Anaesthesia 1992;47:646-52.
  • Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry 2002;63:38-43.
  • Bogetto F, Ferro G, Maina G, Gandolfo S. Amisulpride vs paroxetine in the treatment of burning mouth syn- drome (BMS). Biol Psychiatry 1997;42:27S.
  • Epstein JB, Marcoe JH. Topical application of cap- saicin for treatment of oral neuropathic pain and trigeminal neuralgia. Oral Surg Oral Med Oral Pathol 1994;77:135-40.
  • Simone DA, Ochoa J. Early and late effects of pro- longed topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans. Pain 1991; 47:285-94.
  • Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syn- drome: short-term results of a pilot study. J Oral Pathol Med 2004;33:111-4.